|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500111967 |
|
最近更新日期: Date of Last Refreshed on: |
2025-11-07 17:02:49 |
|
注册时间: Date of Registration: |
2025-11-07 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
社区肌少症老年人高强度间歇训练的支持性干预方案构建及初步应用 |
|
Public title: |
Development and Preliminary Application of a Supportive High-Intensity Interval Training Intervention Program for Community-Dwelling Older Adults with Sarcopenia |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
社区肌少症老年人高强度间歇训练的支持性干预方案构建及初步应用 |
|
Scientific title: |
Development and Preliminary Application of a Supportive High-Intensity Interval Training Intervention Program for Community-Dwelling Older Adults with Sarcopenia |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
常景 |
研究负责人: |
冯辉;常景 |
|
Applicant: |
Chang Jing |
Study leader: |
Feng Hui; Chang Jing |
|
申请注册联系人电话: Applicant telephone: |
+86 133 3531 0120 |
研究负责人电话:
Study leader's |
+86 151 7312 1969 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
769392057@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
feng.hui@csu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
Central South University Xiangya School of Nursing |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
湖南省长沙市岳麓区桐梓坡路172号 |
研究负责人通讯地址: |
湖南省长沙市岳麓区桐梓坡路172号 |
|
Applicant address: |
No. 172 Tongzipo Road, Yuelu District, Changsha City, Hunan Province |
Study leader's address: |
No. 172 Tongzipo Road, Yuelu District, Changsha City, Hunan Province |
|
申请注册联系人邮政编码: Applicant postcode: |
410000 |
研究负责人邮政编码: Study leader's postcode: |
410000 |
|
申请人所在单位: |
中南大学 |
||
|
Applicant's institution: |
Central South University |
||
|
研究负责人所在单位: |
中南大学 |
||
|
Affiliation of the Leader: |
Central South University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
E202521 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中南大学湘雅护理学院伦理审查委员会 |
||
|
Name of the ethic committee: |
Ethics Review Committee of Xiangya School of Nursing, Central South University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-02-13 00:00:00 | ||
|
伦理委员会联系人: |
杨敏 |
||
|
Contact Name of the ethic committee: |
Yang Min |
||
|
伦理委员会联系地址: |
湖南省长沙市岳麓区桐梓坡路172号 |
||
|
Contact Address of the ethic committee: |
No. 172 Tongzipo Road, Yuelu District, Changsha City, Hunan Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 180 7318 5501 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中南大学湘雅护理学院 |
||||||||||||||||||||||
|
Primary sponsor: |
Xiangya School of Nursing, Central South University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖南省长沙市岳麓区桐梓坡路172号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 172 Tongzipo Road, Yuelu District, Changsha City, Hunan Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
湖南省重点研发计划(2025JK2118) |
||||||||||||||||||||||
|
Source(s) of funding: |
the Key Research and Development Program of Hunan Province (2025JK2118) |
||||||||||||||||||||||
|
研究疾病: |
肌少症 |
||||||||||||||||||||||
|
Target disease: |
Sarcopenia |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
(1) 构建社区肌少症老年人的高强度间歇训练支持性干预方案。 (2) 探讨高强度间歇训练支持性干预方案的可行性和可接受性。 |
||||||||||||||||||||||
|
Objectives of Study: |
(1) Develop a high-intensity interval training (HIIT) supportive intervention program for community-dwelling older adults with sarcopenia. (2) Investigate the feasibility and acceptability of the HIIT supportive intervention program. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)年龄≥60 岁的社区老年人; (2)肌少症人群,采用2019年亚洲肌少症社区诊断标准: 1)小腿围:(男性<34cm,女性<33cm); 2)肌肉力量下降:握力(男性<28kg,女性<18kg)或躯体功能下降:5次起坐时间>12s或6米徒步速度<1m/s; (3)具有智能手机/平板电脑使用经验或对其有一定的接受度; (4)知情同意,能够积极参与本研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Community-dwelling older adults aged >=60 years; (2) Individuals with sarcopenia, diagnosed using the 2019 Asian Community-Based Sarcopenia Diagnostic Criteria: 1) Calf circumference: (men <34cm, women <33cm); 2) Reduced muscle strength: grip strength (men < 28 kg, women < 18 kg) or diminished physical function: 5-repetition sit-to-stand time > 12 seconds or 6-meter walk speed < 1 m/s; (3) Experience using smartphones/tablets or willingness to learn; (4) Informed consent and ability to actively participate in this study. |
||||||||||||||||||||||
|
排除标准: |
(1)有严重的运动禁忌症,如严重关节炎、骨折等; (2)合并精神疾病; (3)患有严重疾病或慢性病急性加重。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Severe contraindications to exercise, such as severe arthritis or fractures; (2) Coexisting mental disorders; (3) Acute exacerbation of severe or chronic illnesses. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-12-01 00:00:00至 To 2026-02-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-12-01 00:00:00 至 To 2026-02-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
No |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
none |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
采用电子版问卷以及移动平台后台收集数据;电子版数据使用Excel、SPSS软件录入管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection was conducted using electronic questionnaires and a mobile platform backend; electronic data were entered and managed using Excel and SPSS software. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |